PapersPMID:30895694
The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- RCT · 8 weeks
- Dose studied, every finding
- 10 g/day purslane seeds sachet, before breakfast and dinner, for 8 weeks
- Population, every finding
- adults with nonalcoholic fatty liver disease, low-calorie diet in both arms
What moved
How to read these marks →“Intake of purslane seeds with the low-calorie diet led to a significant decrease in serum concentrations of fasting blood sugar (FBS; -3.52 ± 10.45 compared with 3.03 ± 9.01 mg/dl, P = 0.017), quantitative insulin sensitivity check index (QUICKI; 0.13 ± 0.27 compared with -0.002 ± 0.016, P = 0.017), total cholesterol (4.33 ± 34.04 compared with 23.48 ± 29.47 mg/dl, P = 0.032), and low-density lipoprotein cholesterol (LDL-C; -4.35 ± 22.65 compared with 11.82 ± 16.08 mg/dl, P = 0.004) after intervention.”
- Decreases fasting blood glucose
very limited
- Decreases total cholesterol (TC)
very limited
- Decreases LDL cholesterol
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Individuals with NAFLD; whole purslane (Portulaca oleracea) seeds 10 g/day plus low-calorie diet vs low-calorie diet alone; open control (no placebo); abstract only
- Participants
- 54
- Comparator
- no treatment
- Duration
- 56 days
- Endpoints measured
- 8